Countagen

Countagen is a Stockholm-based biotechnology company providing the new gold standard for high-resolution genome editing Quality Control (QC). We developed LockSeq—a novel targeted multiplex NGS library preparation platform—to solve the "Validation Wall" inherent in traditional PCR-based library preps. By utilizing a unique gap-fill ligation-lock chemistry, we fundamentally eliminate target dropout and amplification bias, providing researchers with the confidence required for preclinical and IND-enabling studies. The LockSeq Advantage- Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction- High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency- Broad Compatibility: Platform-neutral performance across Illumina and Oxford Nanopore systems- Cost-Efficient Scalability: Scale panels and samples with zero target dropout. Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna. Visit us at: